english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2018 Recap > Methotrexate: room for improvement in packaging and patient information (5/2018)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2018
Methotrexate: room for improvement in packaging and patient information (May 2018)

Paris, 29 May 2018

Summary

Prescrire took part in the informal consultation undertaken by the Pharmacovigilance and Risk Assessment Committee (PRAC, the EMA’s medicines safety body), regarding medication errors due to daily instead of weekly administration of methotrexate in non-oncologic indications, and evaluating the effectiveness of risk minimisation measures intended to prevent such errors. Prescrire urges that several root causes which are within the remit of the European Medicines Agency, such as regulation, packaging, labelling and medication safety awareness, not be overlooked.

©Prescrire 2018

> Download Prescrire's response to the PRAC consultation (pdf, 144 Ko)

Share Share on Facebook Share on Twitter